Overview of Dr. Bomback
Dr. Andrew Bomback is a nephrologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 14 years. Dr. Bomback accepts several types of health insurance, listed below. He is one of 165 doctors at New York-Presbyterian Hospital and one of 69 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Nephrology. He has more than 100 publications and over 500 citings.
Office
622 W 168th St
Ph 4-124
New York, NY 10032
Education & Training
- University of North Carolina HospitalsResidency, Internal Medicine, 2004 - 2008
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2009 - 2026
- NJ State Medical License 2022 - 2025
- CT State Medical License 2022 - 2023
- NC State Medical License 2004 - 2009
- American Board of Internal Medicine Nephrology
Clinical Trials
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Start of enrollment: 2009 Feb 01
- Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
- MEmbranous Nephropathy Trial Of Rituximab Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Glucocorticoid Exposure and Infection in Children and Adults With Glomerular Disease: Findings From the Cure Glomerulonephropathy Study.Dorey A Glenn, Calvin Andrews, Qian Liu, Jarcy Zee, Sarah Mansfield
American Journal of Kidney Diseases. 2025-04-01 - Family History in the Context of CKD.Francesca Zanoni, Maddalena Marasa, Lucrezia Carlassara, Miguel Verbitsky, Atlas Khan
Journal of the American Society of Nephrology. 2025-03-11 - 2 citationsSafety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial.Andrew S Bomback, Leal C Herlitz, Priyanka Punit Kedia, Jeffrey Petersen, Huibin Yue
Journal of the American Society of Nephrology. 2025-03-01
Other
- Diagnosis and classification of renal disease in systemic lupus erythematosusBomback AS, Appel GB
http://www.uptodate.com/contents/diagnosis-and-classification-of-renal-disease-in-systemic-lupus-ery
UpToDate, Wolters Kluwer Health - 2013-02-28 - End-stage renal disease due to lupus nephritisBomback AS, Appel GB
http://www.uptodate.com/contents/end-stage-renal-disease-due-to-lupus-nephritis
UpToDate, Wolters Kluwer Health - 2013-04-12
Press Mentions
- Immunosuppressive and Anti-Complement Therapies in C3 GlomerulopathyMarch 24th, 2025
- The Impact of Health Disparities in IgA NephropathyMarch 5th, 2025
- Looking Back at an Early Patient Encounter and the Changing Treatment Landscape in IgA NephropathyMarch 5th, 2025
- Join now to see all
Grant Support
- The Columbia PCC for CureGN: the Cure Glomerulonephropathy networkCOLUMBIA UNIVERSITY HEALTH SCIENCES2013–2029
- The Impact of Diabetes on Patients with Glomerular Disease: CureGN-DiabetesUNIV OF NORTH CAROLINA CHAPEL HILL2021–2027
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Florida BlueSelect
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Wyoming BlueChoice Personal
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
Empire BCBS HMOEmpire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: